Please login to the form below
Evenity back on track with FDA panel blessing in osteoporosis
US drugs regulator first rejected the drug due to cardiovascular concerns
NICE gives Lilly’s Verzenios chance to compete with rivals
Breast cancer drug also being appraised in novel combination
J&J’s Erleada cleared for early prostate cancer in Europe
Signals competiton for Xtandi
GCI Health expands into Asia, Lucid adds to Futures Academy and more
Latest news in med comms
China approves Ironwood Pharma’s IBS treatment
Coincides with AZ's Mark Mallon taking over as CEO
FDA expecting boom in cell and gene therapies
Pledges clampdown on developers working outside regulations
Industry pleads for compromise after Brexit defeat
Prime Minister is more boxed in than ever, but unlikely to be toppled
NHS tech leader departs for digital GP service
Hands baton over to Health Innovation Network chief
EU approval for Opdivo combo in renal cell cancer
BMS one step ahead of rivals
‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’
Brexit means pharma must review its intellectual property rights across Europe
-
The shifting healthcare landscape -
The power of pharma businesses to drive social changeThe importance of CSR programmes
-
Crunch time as Brexit deal faces ‘meaningful vote’Rejecting the deal would either result in a no deal or no Brexit, warns May
-
FDA moves into crisis mode as shutdown drags onNew drug appraisals already being affected
-
Global ban on pharma freebies, including cultural giftsNew rules cover mooncakes and bereavement payments
-
AZ’s Sean Bohen to exit after business overhaul; reportRecent departures raises concern among analysts
-
Chinese biotechs aim PD-L1 antibody at hepatitis BCancer therapies could help boost patient's immune system
-
Blackwood returns as new life sciences ministerReplaces James O’Shaughnessy at DHSC
-
Time running out for ‘no-deal’ Brexit medicines lawsNeeds parliament clearance before 29 March
Latest appointments
-
New faces at Lucid, 90Ten and Page & Page The latest movers in med comms
-
New hires at Nanoform, Leo Pharma and CalliditasThe latest movers in pharma and biotech
-
Changes at Oxford PharmaGenesis, Reynolds-Mackenzie and moreThe latest movers in healthcare comms
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMOLatest movers in pharma and biotech
-
New hires at Mundipharma, Sinclair Pharma and Relay TherapeuticsLatest movers in pharma
Featured jobs
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Medical Writer
-
Salary TBC
-
Associate Director
-
£75, 000-90, 000
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Manager / Account Director
-
Competative
-
Business Director
-
Competitive Salary Offered
-
Senior Medical Writer
-
Salary TBC
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Director, Medical Education
-
Salary TBC
-
Account Director
-
Competitive Salary Offered
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Senior Account Manager
-
Competitive Salary Offered
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
Subscribe to our email news alerts
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
- NICE gives Lilly’s Verzenios chance to compete with rivals
- J&J’s Erleada cleared for early prostate cancer in Europe
- New faces at Lucid, 90Ten and Page & Page
PMHub
Creative Medical Research
Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
